急性早幼粒细胞白血病早期死亡危险因素分析(3)
[3] Zhu HH，Wu DP，Jin J，et al. Oral tetra-arsenic tetra-sulfide formula versus intravenous arsenic trioxide as first-line treatment of acute promyelocytic leukemia：A multicenter randomized controlled trial[J]. J Cell Biol，2013，31(33)：4215-4221.[4] Chendamarai E ......
您现在查看是摘要页，全文长 2207 字符。